These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 25987234)

  • 21. Prognostic implications of stress modality on mortality risk and cause of death in patients undergoing office-based SPECT myocardial perfusion imaging.
    Poulin MF; Alexander S; Doukky R
    J Nucl Cardiol; 2016 Apr; 23(2):202-11. PubMed ID: 25788401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrocardiographic changes during vasodilator SPECT myocardial perfusion imaging: does it affect diagnosis or prognosis?
    Azemi T; Rai M; Parwani P; Baghdasarian S; Kazi F; Ahlberg AW; Cyr G; Katten D; O'Sullivan D; Fram D; Heller GV
    J Nucl Cardiol; 2012 Feb; 19(1):84-91. PubMed ID: 21947978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of caffeine on SPECT myocardial perfusion imaging during regadenoson pharmacologic stress: rationale and design of a prospective, randomized, multicenter study.
    Tejani FH; Thompson RC; Iskandrian AE; McNutt BE; Franks B
    J Nucl Cardiol; 2011 Feb; 18(1):73-81. PubMed ID: 21082298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential risk reclassification improvement by exercise testing and myocardial perfusion imaging in patients with suspected and known coronary artery disease.
    Koh AS; Gao F; Chin CT; Keng FY; Tan RS; Chua TS
    J Nucl Cardiol; 2016 Jun; 23(3):366-78. PubMed ID: 26358085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The reproducibility and prognostic value of serial measurements of heart rate response to regadenoson during myocardial perfusion imaging.
    Andrikopoulou E; AlJaroudi WA; Farag A; Lester D; Patel H; Iskandrian AE; Hage FG
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(8):1493-502. PubMed ID: 27079736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The EXERRT trial: "EXErcise to Regadenoson in Recovery Trial": A phase 3b, open-label, parallel group, randomized, multicenter study to assess regadenoson administration following an inadequate exercise stress test as compared to regadenoson without exercise for myocardial perfusion imaging using a SPECT protocol.
    Thomas GS; Cullom SJ; Kitt TM; Feaheny KM; Ananthasubramaniam K; Gropler RJ; Jain D; Thompson RC
    J Nucl Cardiol; 2017 Jun; 24(3):788-802. PubMed ID: 28224449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regadenoson induces comparable left ventricular perfusion defects as adenosine: a quantitative analysis from the ADVANCE MPI 2 trial.
    Mahmarian JJ; Cerqueira MD; Iskandrian AE; Bateman TM; Thomas GS; Hendel RC; Moye LA; Olmsted AW
    JACC Cardiovasc Imaging; 2009 Aug; 2(8):959-68. PubMed ID: 19679284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prognostic utility of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease: The largest cohort to date.
    Kolkailah AA; Iskander M; Iskander F; Patel PP; Khan R; Doukky R
    J Nucl Cardiol; 2022 Feb; 29(1):101-110. PubMed ID: 32632913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accuracy of
    Brophey MD; Farukhi IM; Castanon R; DeLaPena R; Bradshaw L; Banerjee S
    J Nucl Med Technol; 2017 Jun; 45(2):75-81. PubMed ID: 28408703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prognostic value of regadenoson SPECT myocardial perfusion imaging: The largest cohort to date.
    Kattoor AJ; Kolkailah AA; Iskander F; Iskander M; Diep L; Khan R; Doukky R
    J Nucl Cardiol; 2021 Dec; 28(6):2799-2807. PubMed ID: 32383079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incremental prognostic value of (99m)Tc-tetrofosmin myocardial SPECT after percutaneous coronary intervention.
    Georgoulias P; Tzavara C; Demakopoulos N; Giannakou S; Valotassiou V; Tsougos I; Xaplanteris P; Fezoulidis I
    Ann Nucl Med; 2008 Dec; 22(10):899-909. PubMed ID: 19142709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regadenoson: a focused update.
    Ghimire G; Hage FG; Heo J; Iskandrian AE
    J Nucl Cardiol; 2013 Apr; 20(2):284-8. PubMed ID: 23229649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of atrioventricular block with vasodilator stress SPECT: A meta-analysis.
    Andrikopoulou E; Morgan CJ; Brice L; Bajaj NS; Doppalapudi H; Iskandrian AE; Hage FG
    J Nucl Cardiol; 2019 Apr; 26(2):616-628. PubMed ID: 29043556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical value of single photon emission computed tomography myocardial perfusion imaging in cardiac risk stratification of very elderly patients (≥80 years) with suspected coronary artery disease.
    Nair SU; Ahlberg AW; Mathur S; Katten DM; Polk DM; Heller GV
    J Nucl Cardiol; 2012 Apr; 19(2):244-55. PubMed ID: 22071954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A blunted heart rate response to regadenoson is an independent prognostic indicator in patients undergoing myocardial perfusion imaging.
    Hage FG; Dean P; Iqbal F; Heo J; Iskandrian AE
    J Nucl Cardiol; 2011 Dec; 18(6):1086-94. PubMed ID: 21785922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of normal regadenoson stress perfusion cardiovascular magnetic resonance.
    Freed BH; Narang A; Bhave NM; Czobor P; Mor-Avi V; Zaran ER; Turner KM; Cavanaugh KP; Chandra S; Tanaka SM; Davidson MH; Lang RM; Patel AR
    J Cardiovasc Magn Reson; 2013 Dec; 15(1):108. PubMed ID: 24359617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk stratification among diabetic patients undergoing stress myocardial perfusion imaging.
    Ghatak A; Padala S; Katten DM; Polk DM; Heller GV
    J Nucl Cardiol; 2013 Aug; 20(4):529-38. PubMed ID: 23703380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of 14-year cardiovascular outcomes by dobutamine stress
    Roest S; Boiten HJ; van Domburg RT; Valkema R; Schinkel AFL
    J Nucl Cardiol; 2018 Feb; 25(1):63-71. PubMed ID: 27381341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety of vasodilator stress myocardial perfusion imaging in patients with elevated cardiac biomarkers.
    Rai M; Ahlberg AW; Marwell J; Chaudhary W; Savino JA; Alter EL; Henzlova MJ; Duvall WL
    J Nucl Cardiol; 2017 Apr; 24(2):724-734. PubMed ID: 26902485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and prognostic value of regadenoson stress cardiovascular magnetic resonance imaging in heart transplant recipients.
    Kazmirczak F; Nijjar PS; Zhang L; Hughes A; Chen KA; Okasha O; Martin CM; Akçakaya M; Farzaneh-Far A; Shenoy C
    J Cardiovasc Magn Reson; 2019 Jan; 21(1):9. PubMed ID: 30674318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.